Effects of long non-coding RNA EMX2OS on proliferation,migration and invasion of cervical cancer cells through miR-150/TP53 axis
WANG Jing
CAI Yalei
HU Chaoyue
LI Teng
QI Peng
YANG Jian
Abstract:Objective To explore the role of EMX2 opposite strand/antisense RNA(EMX2OS)in proliferation,migration and invasion of cervical cancer cells through targeting microRNA-150(miR-150)/tumor protein p53(TP53)axis.Methods Real-time quantitative polymerase chain reaction(qPCR)was used to detect levels of EMX2OS and miR-150 in cervical cancer cells.C-33A cells were transfected with EMX2OS overexpression vector pcDNA3.1-EMX2OS or miR-150 mimics,and divided into 4 groups:pcDNA3.1 group,pcDNA3.1-EMX2OS group(overexpression of EMX2OS),pcDNA3.1-EMX2OS+miR-NC group and pcDNA3.1-EMX2OS+miR-150 mimics group(overexpression of EMX2OS and miR-150).Cell growth,migration and invasion were monitored by MTT,wound-healing and Transwell assays.The interaction relationships between EMX2OS/miR-150 and miR-150/TP53 were analyzed by dual-luciferase reporter.Results EMX2OS was decreased in cervical cancer cells,while miR-150 was increased(P<0.05).Compared with pcDNA3.1 group,the cell proliferation activity,healing rate,the number of invaded cells and miR-150 expression were curtailed in pcDNA3.1-EMX2OS group,while the expression of TP53 was promoted(P<0.05).Compared with pcDNA3.1-EMX2OS+miR-NC group,the cell proliferation activity,healing rate,the number of invaded cells and miR-150 expression were elevated in pcDNA3.1-EMX2OS+miR-150 mimics group,while the expression of TP53 was declined(P<0.05).Both EMX2OS and TP53 bounded to miR-150.Conclusion EMX2OS suppressed cell growth,migration,and invasion possibly via the miR-150/TP53 axis in cervical cancer,which could be a potential target for treating cervical cancer patients.
Keywords:Cervical cancerEMX2 opposite strand/antisense RNAMicroRNA-150Tumor protein p53
Publication Date:2023-12-28
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:7( 961-967 )
Chinese Clinical Oncology

Chinese Clinical Oncology

ISTIC
ISSN:1009-0460
Year, Vol.(Issue):2023,28(12)